Fintan Ryan analyst JPMORGAN

Currently out of the existing stock ratings of Fintan Ryan, 24 are a BUY (85.71%), 1 are a SELL (3.57%), 3 are a HOLD (10.71%).

Fintan Ryan

Work Performance Price Targets & Ratings Chart

Analyst Fintan Ryan, currently employed at JPMORGAN, carries an average stock price target met ratio of 90% that have a potential upside of 47.24% achieved within 710 days. Previously, Fintan Ryan worked at BTIG, BERENBERG.

Fintan Ryan’s has documented 54 price targets and ratings displayed on 5 stocks. The coverage is on Consumer Defensive, Basic Materials, Technology sectors.

Most recent stock forecast was given on CCEP, Coca-Cola European Partners PLC at 27-Nov-2024.

Wall Street Analyst Fintan Ryan

Analyst best performing recommendations are on CC (CHEMOURS CO).
The best stock recommendation documented was for CC (CHEMOURS CO) at 3/14/2022. The price target of $24.91 was fulfilled within 2 days with a profit of $0.98 (4.1%) receiving and performance score of 20.48.

Average potential price target upside

CCEP Coca-Cola European Partners PLC CABGY Carlsberg AS SXT Sensient Technologies CC Chemours Co DV DoubleVerify Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-May-2021

$114

$4.54 (4.15%)

$108

13 days ago
(21-Jul-2026)

32/33 (96.97%)

$8.81 (8.38%)

378

Buy Since 26-Feb-2024

$109

$-0.46 (-0.42%)

$118

3 months 5 days ago
(29-Apr-2026)

7/8 (87.5%)

$15.25 (16.27%)

188

Buy Since 05-Dec-2023

$110

$0.54 (0.49%)

5 months 16 days ago
(18-Feb-2026)

5/5 (100%)

$5.33 (5.09%)

179

Buy Since 22-Feb-2022

$112

$2.54 (2.32%)

$90

5 months 16 days ago
(18-Feb-2026)

4/5 (80%)

$7.33 (7.00%)

332

Buy Since 09-Mar-2022

$96

$-13.46 (-12.30%)

$102

6 months 20 days ago
(14-Jan-2026)

4/4 (100%)

$7.16 (8.06%)

90

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Fintan Ryan?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?